• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解 COPD 患者药物依从性的障碍和策略:一项定性研究。

Understanding barriers to and strategies for medication adherence in COPD: a qualitative study.

机构信息

Division of Pulmonary and Critical Care, Johns Hopkins University School of Medicine, Baltimore, USA.

出版信息

BMC Pulm Med. 2022 Mar 19;22(1):98. doi: 10.1186/s12890-022-01892-5.

DOI:10.1186/s12890-022-01892-5
PMID:35305609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8934480/
Abstract

BACKGROUND

Medication adherence in chronic obstructive pulmonary disease (COPD) is low, though not enough is known about the factors that affect adherence in COPD. This study uses qualitative methods to understand the patient perspective on facilitators and barriers to medication adherence in COPD as well as patient-reported strategies for self-management of disease.

METHODS

Semi-structured interviews were conducted with 30 individuals (n = 30). Transcripts were analyzed using iterative qualitative coding by 2 independent coders, and codes were categorized using thematic analysis.

RESULTS

Challenges with adherence reported were gaps in understanding, forgetfulness of the patient, physician availability, cost navigation, and overcoming substance use. Most commonly, the financial burden of COPD medications caused patients to source other countries to obtain medications, rely on sample medications collected during doctors' visits, and to alter medication dosage and frequency to extend the length of a prescription. Tools and resources reported by patients to support self-management of COPD included pharmacist assistance, physician office information, and community resources. Individuals further reported that the use of logs or diaries to track medication usage, visual or temporal cues to take medications, and support from family members were helpful in promoting adherence to their COPD medication regimen.

CONCLUSIONS

Medication adherence in individuals with COPD is affected by challenges with self-management of disease and financial burden of medications. However, patients reported multiple tools and resources to support adherence. Physician recognition of these factors impacting self-management, as well as awareness of strategies to promote adherence and manage disease, may improve patient outcomes.

摘要

背景

慢性阻塞性肺疾病(COPD)患者的药物依从性较低,但对于影响 COPD 患者药物依从性的因素了解甚少。本研究采用定性方法,从患者角度了解 COPD 患者药物依从性的促进因素和障碍因素,以及患者自我管理疾病的报告策略。

方法

对 30 名个体(n=30)进行了半结构化访谈。两名独立编码员使用迭代定性编码对转录本进行分析,并使用主题分析对代码进行分类。

结果

报告的依从性挑战包括理解上的差距、患者健忘、医生可用性、成本导航以及克服药物滥用。最常见的是,COPD 药物的经济负担导致患者从其他国家获取药物,依赖于医生就诊时收集的样本药物,以及改变药物剂量和频率以延长处方的长度。患者报告支持 COPD 自我管理的工具和资源包括药剂师协助、医生办公室信息和社区资源。个人进一步报告说,使用日志或日记来跟踪药物使用情况、使用视觉或时间提示来服用药物以及家庭成员的支持有助于促进他们对 COPD 药物治疗方案的依从性。

结论

COPD 患者的药物依从性受到疾病自我管理和药物经济负担的挑战的影响。然而,患者报告了多种支持依从性的工具和资源。医生认识到这些影响自我管理的因素,以及提高依从性和管理疾病的策略的意识,可能会改善患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a921/8934480/73a08ed7c6ba/12890_2022_1892_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a921/8934480/73a08ed7c6ba/12890_2022_1892_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a921/8934480/73a08ed7c6ba/12890_2022_1892_Fig1_HTML.jpg

相似文献

1
Understanding barriers to and strategies for medication adherence in COPD: a qualitative study.了解 COPD 患者药物依从性的障碍和策略:一项定性研究。
BMC Pulm Med. 2022 Mar 19;22(1):98. doi: 10.1186/s12890-022-01892-5.
2
Facilitators and barriers to the self-management of COPD: a qualitative study from rural Nepal.农村尼泊尔慢性阻塞性肺疾病自我管理的促进因素和障碍:一项定性研究。
BMJ Open. 2020 Mar 9;10(3):e035700. doi: 10.1136/bmjopen-2019-035700.
3
Experiences and Factors Affecting Usage of an eHealth Tool for Self-Management Among People With Chronic Obstructive Pulmonary Disease: Qualitative Study.慢性阻塞性肺疾病患者使用电子健康工具进行自我管理的体验及影响因素:定性研究。
J Med Internet Res. 2021 Apr 30;23(4):e25672. doi: 10.2196/25672.
4
Facilitators and barriers to self-management in Iranian men with chronic obstructive pulmonary disease: a qualitative study.伊朗慢性阻塞性肺疾病男性患者自我管理的促进因素和障碍:一项定性研究。
BMJ Open Respir Res. 2024 May 15;11(1):e002245. doi: 10.1136/bmjresp-2023-002245.
5
Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy.患者对哮喘长期控制药物治疗障碍与促进因素的看法:一种新的分类法。
BMC Pulm Med. 2015 Apr 25;15:42. doi: 10.1186/s12890-015-0044-9.
6
Benefits of the 'village': a qualitative exploration of the patient experience of COPD in rural Australia.“村落”的益处:对澳大利亚农村慢性阻塞性肺疾病患者体验的质性探索
BMJ Open. 2019 Oct 7;9(10):e030953. doi: 10.1136/bmjopen-2019-030953.
7
Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: A systematic review and meta-analysis.药师主导的干预措施对哮喘或 COPD 成年患者药物依从性和吸入技术的影响:系统评价和荟萃分析。
J Clin Pharm Ther. 2020 Oct;45(5):904-917. doi: 10.1111/jcpt.13126. Epub 2020 Feb 27.
8
Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.在社区药房环境中,自我报告患有 COPD 的个体的症状负担和呼吸药物依从性评估。
J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4):479-488.e1. doi: 10.1016/j.japh.2019.04.017. Epub 2019 May 22.
9
Exploring medicines management by COPD patients and their social networks after hospital discharge.探索慢性阻塞性肺疾病患者出院后及其社交网络的药物管理情况。
Int J Clin Pharm. 2018 Oct;40(5):1019-1029. doi: 10.1007/s11096-018-0688-7. Epub 2018 Jul 28.
10
Adherence to Maintenance Medications among Older Adults with Chronic Obstructive Pulmonary Disease. The Role of Depression.慢性阻塞性肺疾病老年患者对维持性药物的依从性。抑郁症的作用。
Ann Am Thorac Soc. 2016 Sep;13(9):1497-504. doi: 10.1513/AnnalsATS.201602-136OC.

引用本文的文献

1
Evaluating the impact of self-management interventions on COPD outcomes in low- and middle-income countries in Asia: a systematic review.评估自我管理干预措施对亚洲低收入和中等收入国家慢性阻塞性肺疾病结局的影响:一项系统评价。
Health Qual Life Outcomes. 2025 Aug 30;23(1):81. doi: 10.1186/s12955-025-02382-y.
2
Latent profile analysis for medication adherence in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者药物依从性的潜在类别分析
BMC Pulm Med. 2025 Jul 30;25(1):363. doi: 10.1186/s12890-025-03859-8.
3
Self-management and COPD: a qualitative study to explore the perceived barriers and recommendations to improve COPD management using the Information-Motivation-Behavioral skills model.

本文引用的文献

1
Patient experience of COPD care: outcomes from the British Lung Foundation Patient Passport.患者对 COPD 护理的体验:英国肺脏基金会患者护照的研究结果。
BMJ Open Respir Res. 2019 Oct 3;6(1):e000478. doi: 10.1136/bmjresp-2019-000478. eCollection 2019.
2
Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population.美国商业保险人群中接受三联疗法的慢性阻塞性肺疾病患者的药物依从性和持续性
Int J Chron Obstruct Pulmon Dis. 2019 Feb 19;14:343-352. doi: 10.2147/COPD.S184653. eCollection 2019.
3
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
自我管理与慢性阻塞性肺疾病:一项质性研究,旨在运用信息-动机-行为技能模型探索慢性阻塞性肺疾病管理中感知到的障碍及改进建议。
NPJ Prim Care Respir Med. 2025 Jul 26;35(1):34. doi: 10.1038/s41533-025-00443-9.
4
Identification of Psychosocial and Sociodemographic Factors Associated with Low Medication Awareness in COPD Subjects: A Cross-Sectional Study, Findings from the Indonesian Family Life Survey 5.慢性阻塞性肺疾病(COPD)患者中与低药物认知相关的心理社会和社会人口学因素的识别:一项横断面研究,来自印度尼西亚家庭生活调查5的结果
Int J Chron Obstruct Pulmon Dis. 2025 Apr 9;20:1009-1026. doi: 10.2147/COPD.S498302. eCollection 2025.
5
Barriers and facilitators of adherence to treatment interventions for COPD amongst individuals from minority ethnic communities: Meta-ethnography.少数族裔社区个体对慢性阻塞性肺疾病治疗干预措施依从性的障碍与促进因素:元民族志研究
PLoS One. 2025 Feb 10;20(2):e0318709. doi: 10.1371/journal.pone.0318709. eCollection 2025.
6
Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease.糠酸氟替卡松/乌美溴铵/维兰特罗与布地奈德/格隆溴铵/富马酸福莫特罗在美国慢性阻塞性肺疾病患者中的疗效比较
Adv Ther. 2025 Feb;42(2):1131-1146. doi: 10.1007/s12325-024-03088-1. Epub 2024 Dec 28.
7
Comparative adherence and persistence of single-inhaler and multiple-inhaler triple therapies among patients with chronic obstructive pulmonary disease in Japan: a retrospective cohort study.日本慢性阻塞性肺疾病患者中单一吸入器与多吸入器三联疗法的依从性和持续性比较:一项回顾性队列研究
BMJ Open. 2024 Dec 4;14(12):e080864. doi: 10.1136/bmjopen-2023-080864.
8
Perspectives on Treatment Decisions, Preferences, and Adherence and Long-Term Management in Asthma and COPD: A Qualitative Analysis of Patient, Caregiver, and Healthcare Provider Insights.哮喘和慢性阻塞性肺疾病治疗决策、偏好、依从性及长期管理的观点:对患者、护理人员及医疗服务提供者见解的定性分析
Patient Prefer Adherence. 2024 Nov 14;18:2295-2306. doi: 10.2147/PPA.S467870. eCollection 2024.
9
Fluticasone Furoate/Umeclidinium/Vilanterol Initiation Following a COPD Exacerbation: Benefits of Prompt Initiation on COPD Outcomes.糠酸氟替卡松/乌美溴铵/维兰特罗起始治疗 COPD 加重:早期起始治疗对 COPD 结局的获益。
Adv Ther. 2024 Dec;41(12):4557-4580. doi: 10.1007/s12325-024-02999-3. Epub 2024 Oct 25.
10
Facilitators and barriers to self-management in Iranian men with chronic obstructive pulmonary disease: a qualitative study.伊朗慢性阻塞性肺疾病男性患者自我管理的促进因素和障碍:一项定性研究。
BMJ Open Respir Res. 2024 May 15;11(1):e002245. doi: 10.1136/bmjresp-2023-002245.
全球慢性阻塞性肺疾病诊断、管理和预防策略:GOLD 科学委员会报告 2019.
Eur Respir J. 2019 May 18;53(5). doi: 10.1183/13993003.00164-2019. Print 2019 May.
4
Inhaler Review in Older Adults with Asthma or COPD: A Cost-Effectiveness Study and a Perspective in Portugal.老年哮喘或 COPD 患者吸入器评估:一项成本效益研究及葡萄牙视角。
J Am Geriatr Soc. 2019 Jul;67(7):1430-1436. doi: 10.1111/jgs.15834. Epub 2019 Feb 23.
5
Effect of an Asthma Question Prompt List and Video Intervention on Adolescents' Medication Adherence 12 Months Later.哮喘问题提示清单和视频干预对青少年 12 个月后药物依从性的影响。
Ann Pharmacother. 2019 Jul;53(7):683-689. doi: 10.1177/1060028019831259. Epub 2019 Feb 13.
6
COPD: understanding patients' adherence to inhaled medications.慢性阻塞性肺疾病:了解患者对吸入药物的依从性
Int J Chron Obstruct Pulmon Dis. 2018 Sep 6;13:2767-2773. doi: 10.2147/COPD.S160982. eCollection 2018.
7
Evaluation of a structured pharmacist-led inhalation technique assessment service for patients with asthma and COPD in Norwegian pharmacies.评估挪威药店中由药剂师主导的结构化吸入技术评估服务在哮喘和 COPD 患者中的应用。
Patient Educ Couns. 2018 Oct;101(10):1828-1837. doi: 10.1016/j.pec.2018.05.018. Epub 2018 May 22.
8
Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.慢性阻塞性肺疾病患者正确使用吸入器的相关因素——来自真实调查的经验教训
Int J Chron Obstruct Pulmon Dis. 2018 Feb 26;13:695-702. doi: 10.2147/COPD.S149404. eCollection 2018.
9
Specific, but not general beliefs about medicines are associated with medication adherence in patients with COPD, but not asthma: Cohort study in a population of people with chronic pulmonary disease.特定而非一般的药物信念与 COPD 患者的药物依从性相关,但与哮喘无关:慢性肺部疾病人群的队列研究。
J Psychosom Res. 2018 Apr;107:46-52. doi: 10.1016/j.jpsychores.2018.02.004. Epub 2018 Feb 8.
10
Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.实践指南更新概要:轻度认知障碍:美国神经病学学会指南制定、传播和实施小组委员会的报告。
Neurology. 2018 Jan 16;90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27.